Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2013 1
2014 1
2018 3
2019 4
2020 4
2021 2
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
Okuzumi A, Hatano T, Matsumoto G, Nojiri S, Ueno SI, Imamichi-Tatano Y, Kimura H, Kakuta S, Kondo A, Fukuhara T, Li Y, Funayama M, Saiki S, Taniguchi D, Tsunemi T, McIntyre D, Gérardy JJ, Mittelbronn M, Kruger R, Uchiyama Y, Nukina N, Hattori N. Okuzumi A, et al. Among authors: ueno si. Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. Epub 2023 May 29. Nat Med. 2023. PMID: 37248302 Free PMC article.
Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD.
Miyamoto K, Saiki S, Matsumoto H, Suzuki A, Yamashita Y, Iseki T, Ueno SI, Shiina K, Kataura T, Kamagata K, Imamichi Y, Sasazawa Y, Fujimaki M, Akamatsu W, Hattori N. Miyamoto K, et al. Among authors: ueno si. Ann Neurol. 2023 Feb;93(2):303-316. doi: 10.1002/ana.26510. Epub 2022 Oct 4. Ann Neurol. 2023. PMID: 36128871 Free PMC article.
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study.
Hatano T, Oyama G, Shimo Y, Ogaki K, Nishikawa N, Nakamura R, Tsunemi T, Ogawa T, Eguchi H, Daida K, Kurita N, Ueno SI, Fukae J, Sako W, Shiina K, Nakajima S, Oji Y, Wakamori R, Saiki S, Nishioka K, Okuzumi A, Taniguchi D, Takeshige-Amano H, Fuse A, Nakajima A, Kano M, Kamo H, Yamashita Y, Shindo A, Yanagisawa N, Hattori N. Hatano T, et al. Among authors: ueno si. Mov Disord Clin Pract. 2024 Apr;11(4):352-362. doi: 10.1002/mdc3.13972. Epub 2024 Jan 24. Mov Disord Clin Pract. 2024. PMID: 38264844 Free PMC article. Clinical Trial.
Metabolomics-based identification of metabolic alterations in PARK2.
Okuzumi A, Hatano T, Ueno SI, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa KI, Fujimaki M, Sato S, Ramamoorthy S, Mohney RP, Hattori N. Okuzumi A, et al. Among authors: ueno si. Ann Clin Transl Neurol. 2019 Feb 21;6(3):525-536. doi: 10.1002/acn3.724. eCollection 2019 Mar. Ann Clin Transl Neurol. 2019. PMID: 30911576 Free PMC article.
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.
Takeshige-Amano H, Saiki S, Fujimaki M, Ueno SI, Li Y, Hatano T, Ishikawa KI, Oji Y, Mori A, Okuzumi A, Tsunemi T, Daida K, Ishiguro Y, Imamichi Y, Nanmo H, Nojiri S, Funayama M, Hattori N. Takeshige-Amano H, et al. Among authors: ueno si. Mov Disord. 2020 Aug;35(8):1438-1447. doi: 10.1002/mds.28068. Epub 2020 May 1. Mov Disord. 2020. PMID: 32357260 Free PMC article.
Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease.
Koinuma T, Hatano T, Kamagata K, Andica C, Mori A, Ogawa T, Takeshige-Amano H, Uchida W, Saiki S, Okuzumi A, Ueno SI, Oji Y, Saito Y, Hori M, Aoki S, Hattori N. Koinuma T, et al. Among authors: ueno si. J Parkinsons Dis. 2021;11(3):1221-1235. doi: 10.3233/JPD-202495. J Parkinsons Dis. 2021. PMID: 33896850 Free PMC article.
22 results